The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

被引:32
|
作者
Cosi, C [1 ]
Koek, W [1 ]
机构
[1] Ctr Rech Pierre Fabre, Div Neurobiol 2, F-80106 Castres, France
关键词
S-35]GTP gamma S binding; 5-HT1A receptor; inverse agonist; WAY; 100635;
D O I
10.1016/S0014-2999(00)00410-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonist binding to G protein-coupled receptors induces the formation of a receptor-G protein complex and subsequent guanosine 5'-diphosphate/guanosine 5'-triphosphate (GDP/GTP) exchange. Some receptors, however, form receptor-a protein complexes and promote GDP/GTP exchange even when not occupied by agonists. Such receptors preferentially activate pertussis toxin-sensitive G proteins (i.e., G(i)/G(o)), and the interactions of receptors and G proteins are affected by monovalent cations (most notably Na+), both in the occupied and unoccupied state. We investigated the effects of Na+ on the intrinsic activity of 5-hydroxytryptamine,. (5-HT1A) receptor ligands, measured as maximal effect (E-MAX), using guanosine 5'-0-(3-[S-35]thio)-triphosphate ([S-35]GTP gamma S) binding to membranes prepared from human epithelioid carcinoma (HeLa) cells, expressing 500 fmol/mg protein of cloned human 5-HT1A receptor (HA7 cells). A decrease of the NaCl concentration decreased the maximal effect of serotonin, increased basal [S-35]GTP gamma S binding, and increased the negative intrinsic activity of spiperone and N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-N-(2-pyridinyl)cyclohexanecarboxamide (WAY 100635). This ability of WAY 100635 to decrease basal [S-35]GTP gamma S binding was antagonized by (s)-N-tert-butyl-3-(4-(2-methaxyphenyl)piperazine-1-yl)-2-phenylpropanamide ((s)-WAY 100135) (pA(2) = 7.77). Further, WAY 100635 was able to antagonize carboxamidotryptamine (5-CT)-stimulated [S-35]GTP gamma S binding with a pA(2) of 9.9, in standard NaCl conditions, and of 9.7, in the absence of NaCl. Changes in membrane concentration did not affect the ability of WAY 100635 to decrease [S-35]GTP gamma S binding. WAY 100635 did not affect basal [S-35]GTP gamma S binding to membranes from untransfected HeLa cells. Pertussis toxin (200 ng/ml) prevented WAY 100635 and spiperone to decrease [S-35]GTP gamma S binding, showing that their effects were mediated by G proteins of the G(i)/G(o) family. In conclusion, the constitutive and stimulated activity of human 5-HT1A receptors expressed in HA7 cells is sodium-dependent, which allowed to confirm the 5-HT1A inverse agonist properties of spiperone, and to show that WAY 100635 is an inverse agonist at 5-HT1A receptors that inhibits basal [S-35]GTP gamma S binding to a lesser extent than spiperone. [S-35]GTP gamma S binding to membranes from HA7 cells under low NaCl conditions appears to be especially suitable to evidence and pharmacologically analyze the inverse agonist properties of 5-HT1A receptor ligands. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 50 条
  • [31] Involvement of presynaptic 5-HT1A and benzodiazepine receptors in the anticonflict activity of 5-HT1A receptor antagonists
    Wesolowska, A
    Paluchowska, M
    Chojnacka-Wójcik, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 471 (01) : 27 - 34
  • [32] Occupancy of Agonist Drugs at the 5-HT1A Receptor
    R Alexander Bantick
    Eugenii A Rabiner
    Ella Hirani
    Michiel H de Vries
    Susan P Hume
    Paul M Grasby
    Neuropsychopharmacology, 2004, 29 : 847 - 859
  • [33] Occupancy of agonist drugs at the 5-HT1A receptor
    Bantick, RA
    Rabiner, EA
    Hirani, E
    de Vries, MH
    Hume, SP
    Grasby, PM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 847 - 859
  • [34] Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats
    Popova, NK
    Naumenko, VS
    Plyusnina, IZ
    Kulikov, AV
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 80 (02) : 286 - 292
  • [35] Regulation of agonist efficacy at the 5-HT1A receptor
    McLoughlin, DJ
    Evans, KJ
    Clarke, WP
    FASEB JOURNAL, 2001, 15 (04): : A219 - A219
  • [36] Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635
    NewmanTancredi, A
    Conte, C
    Chaput, C
    Spedding, M
    Millan, MJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (05) : 737 - 739
  • [37] Effects of a 5-HT1A receptor agonist (8-OH-DPAT) and antagonist (WAY-100635) on progressive ratio performance
    Ho, MY
    Body, S
    Kheramin, S
    Bradshaw, CM
    Szabadi, E
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A40 - A40
  • [38] Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors
    Newman-Tancredi, A
    Chaput, C
    Gavaudan, S
    Verrièle, L
    Millan, MJ
    NEUROPSYCHOPHARMACOLOGY, 1998, 18 (05) : 395 - 398
  • [39] EFFECT OF THE PUTATIVE 5-HT1A ANTAGONIST WAY100635 ON 5-HT NEURONAL FIRING IN THE GUINEA-PIG DORSAL RAPHE NUCLEUS
    MUNDEY, MK
    FLETCHER, A
    MARSDEN, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U49 - U49
  • [40] The effects of A 5-HT1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: a microdialysis study with flesinoxan and WAY 100635
    Fokko Bosker
    Dorien Vrinten
    André Klompmakers
    H. Westenberg
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 355 : 347 - 353